Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (14.592)

71

FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Anderson, T. | Chang, B. | Huang, A. | +13

72

High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy

enthalten in: Breast cancer research and treatment | 2024

von Wood, S. | Gao, Y. | Lee, J. | +4

73

Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs

enthalten in: The Journal of rheumatology | 2024

von Ruscitti, P. | McGonagle, D. | Garcia, V. | +9

74

Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

enthalten in: Cancer discovery | 2024

von An, M. | Mehta, A. | Min, B. | +16

75

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts

enthalten in: Cancer discovery | 2024

von DiPeri, T. | Evans, K. | Wang, B. | +16

76

Improved small airway dysfunction in severe asthma with clinical remission by anti-interleukin-5/interleukin-5 receptor α

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2024

von Akamatsu, T. | Shirai, T. | Okawa, K. | +1

77

Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Saito, S. | Kono, M. | Nguyen, H. | +6

78

Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women : A Review of the Literature

enthalten in: Current rheumatology reports | 2024

von Ho, W. | Chang, C. | Wu, W. | +4

79

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

80

The UK Divide : Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in Scotland

enthalten in: Clinical oncology (Royal College of Radiologists (Great Britain)) | 2024

von Thapa, A. | Cowell, A. | Peters, A. | +15

CommentIn: Clin Oncol (R Coll Radiol). 2024 Mar 15;:null. - PMID 38565459